Bortezomib 2.5 mg powder for solution for injection

Licence status
Authorised: 22/03/2019
Active substances
Bortezomib
Dosage Form
Powder for solution for injection
Licence number
PA23142/012/003
Licence holder
Aspire Pharma (Malta) Limited

Product documents

Licence information

ATC code
L01XX32 bortezomib
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Marketing availability
Not marketed
Advertising conditions
Advertising to healthcare professionals only
Licence issued
22/03/2019